Bain Capital Life Sciences Investors LLC

Bain Capital Life Sciences Investors LLC latest Q4_2020 13F filings reported $1,592,801,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 48.45%. This fund has 26 securities concentrations of 100% weights.

Bain Capital Life Sciences Investors LLC largest holding is SpringWorks Therapeutics Inc. with weight of 33.15% and $528,040,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR26$1,592,801,00048.45%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
SPRINGWORKS THERAPEUTICS INCSWTXINCR$528,04052.13%33.15%$72.52-100.00%7,281,307
ATEA PHARMACEUTICALS INCAVIRBUY$234,6220.00%14.73%$41.780.00%5,615,659
ARCUTIS BIOTHERAPEUTICS INCARQTDECR$111,937-3.99%7.03%$28.130.00%3,979,292
MERSANA THERAPEUTICS INCMRSNBUY$91,6890.00%5.76%$26.610.00%3,445,667
ANNEXON INCANNXDECR$81,138-17.20%5.09%$25.030.00%3,241,628
DICERNA PHARMACEUTICALS INC COMMON STOCK USD0.0001DRNADECR$67,858-7.55%4.26%$22.03-124.51%3,080,237
SYROS PHARMACEUTICALS INCSYRSBUY$62,7680.00%3.94%$10.850.00%5,785,036
C4 THERAPEUTICS INCCCCCBUY$54,4060.00%3.42%$33.130.00%1,642,209
SOLID BIOSCIENCES INCSLDBINCR$53,517581.05%3.36%$7.58-17.62%7,060,353
DYNAVAX TECHNOLOGIES CORPBUY$48,4860.00%3.04%$4.450.00%10,895,773
NURIX THERAPEUTICS INCNRIXDECR$42,228-5.81%2.65%$32.880.00%1,284,314
CONSTELLATION PHARMCETICLS ICNSTBUY$40,3200.00%2.53%$28.800.00%1,400,000
APTINYX INCAPTXINCR$30,76563.76%1.93%$3.46-40.03%8,891,758
KYMERA THERAPEUTICS INCKYMRINCR$29,73526.13%1.87%$62.00-134.27%479,605
AEGLEA BIOTHERAPEUTICS INCAGLEBUY$21,2490.00%1.33%$7.870.00%2,700,000
MARINUS PHARMACEUTICALS INCDECR$17,459-5.06%1.10%$12.20-100.00%1,431,058
CRINETICS PHARMACEUTICALS INCRNXBUY$15,1180.00%0.95%$14.110.00%1,071,428
THERAPEUTICS ACQUISITION CORRACADECR$13,920-3.20%0.87%$13.920.00%1,000,000
ARYA SCIENCES ACQUISITION COARYAINCR$10,8500.32%0.68%$10.85-100.00%1,000,000
X4 PHARMACEUTICALS INCXFORDECR$10,600-5.02%0.67%$6.430.00%1,648,485
SAVARA INCSVRADECR$5,898-74.33%0.37%$1.150.00%5,128,593
BCTG ACQUISITION CORPBCTGINCR$5,72010.42%0.36%$11.44-100.00%500,000
BCLS ACQUISITION CORPBLSABUY$5,4310.00%0.34%$11.140.00%487,500
FRAZIER LIFESCIENCES ACQU COFLACUBUY$3,1140.00%0.20%$10.380.00%300,000
JIYA ACQUISITION CORPJYACBUY$3,0900.00%0.19%$10.300.00%300,000
HELIX ACQUISITION CORPHLXABUY$2,8430.00%0.18%$11.370.00%250,000
REPLIMUNE GROUP INC USD0.001000REPLSOLD$00.00%-100.00%$0.000.00%0
DYNAVAX TECHNOLOGIES CORPDVAXSOLD$00.00%-100.00%$0.000.00%0
SAGE THERAPEUTICS INCSAGESOLD$00.00%-100.00%$0.000.00%0
PANACEA ACQUISITION CORPSOLD$00.00%-100.00%$0.000.00%0